+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Autoinjectors Market 2024-2028

  • PDF Icon

    Report

  • 176 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5769556
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The autoinjectors market is forecasted to grow byUSD 303.65 billion during 2023-2028, accelerating at a CAGR of 36.72% during the forecast period. The report on the autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies and need for immediate care, growing popularity of injectable therapies, and rise in commercial approvals of new products.

The autoinjectors market is segmented as below:

By Application

  • Anaphylaxis
  • Multiple sclerosis
  • Rheumatoid arthritis
  • Diabetes

By End-user

  • Hospitals and clinics
  • Self-administration

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strategic alliances between companies as one of the prime reasons driving the autoinjectors market growth during the next few years. Also, increase in new product launches and rise in awareness of innovative anaphylaxis autoinjectors will lead to sizable demand in the market.

The report on the autoinjectors market covers the following areas:

  • Autoinjectors market sizing
  • Autoinjectors market forecast
  • Autoinjectors market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoinjectors market vendors that include AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG. Also, the autoinjectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Autoinjectors Market 2018 - 2022
Historic Market Size - Data Table on Global Autoinjectors Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Anaphylaxis - Market size and forecast 2023-2028
Chart on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Data Table on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Chart on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Data Table on Anaphylaxis - Year-over-year growth 2023-2028 (%)
6.4 Multiple sclerosis - Market size and forecast 2023-2028
Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
6.5 Rheumatoid arthritis - Market size and forecast 2023-2028
Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
6.6 Diabetes - Market size and forecast 2023-2028
Chart on Diabetes - Market size and forecast 2023-2028 ($ million)
Data Table on Diabetes - Market size and forecast 2023-2028 ($ million)
Chart on Diabetes - Year-over-year growth 2023-2028 (%)
Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2023-2028
Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.4 Self-administration - Market size and forecast 2023-2028
Chart on Self-administration - Market size and forecast 2023-2028 ($ million)
Data Table on Self-administration - Market size and forecast 2023-2028 ($ million)
Chart on Self-administration - Year-over-year growth 2023-2028 (%)
Data Table on Self-administration - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
12.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.10 Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc. - Overview
Halozyme Therapeutics Inc. - Product / Service
Halozyme Therapeutics Inc. - Key offerings
12.11 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.12 Owen Mumford Ltd.
Owen Mumford Ltd. - Overview
Owen Mumford Ltd. - Product / Service
Owen Mumford Ltd. - Key offerings
12.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.14 Recipharm AB
Recipharm AB - Overview
Recipharm AB - Business segments
Recipharm AB - Key offerings
Recipharm AB - Segment focus
12.15 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12.17 Ypsomed Holding AG
Ypsomed Holding AG - Overview
Ypsomed Holding AG - Business segments
Ypsomed Holding AG - Key offerings
Ypsomed Holding AG - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Autoinjectors Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Application - Market share 2023-2028 (%)
Exhibits 33: Data Table on Application - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Application
Exhibits 35: Data Table on Comparison by Application
Exhibits 36: Chart on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Exhibits 48: Chart on Diabetes - Market size and forecast 2023-2028 ($ million)
Exhibits 49: Data Table on Diabetes - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibits 52: Market opportunity by Application ($ million)
Exhibits 53: Data Table on Market opportunity by Application ($ million)
Exhibits 54: Chart on End-user - Market share 2023-2028 (%)
Exhibits 55: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 56: Chart on Comparison by End-user
Exhibits 57: Data Table on Comparison by End-user
Exhibits 58: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Self-administration - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Self-administration - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Self-administration - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Self-administration - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by End-user ($ million)
Exhibits 67: Data Table on Market opportunity by End-user ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: AbbVie Inc. - Overview
Exhibits 118: AbbVie Inc. - Product / Service
Exhibits 119: AbbVie Inc. - Key news
Exhibits 120: AbbVie Inc. - Key offerings
Exhibits 121: Amgen Inc. - Overview
Exhibits 122: Amgen Inc. - Product / Service
Exhibits 123: Amgen Inc. - Key news
Exhibits 124: Amgen Inc. - Key offerings
Exhibits 125: Bayer AG - Overview
Exhibits 126: Bayer AG - Business segments
Exhibits 127: Bayer AG - Key news
Exhibits 128: Bayer AG - Key offerings
Exhibits 129: Bayer AG - Segment focus
Exhibits 130: Becton Dickinson and Co. - Overview
Exhibits 131: Becton Dickinson and Co. - Business segments
Exhibits 132: Becton Dickinson and Co. - Key news
Exhibits 133: Becton Dickinson and Co. - Key offerings
Exhibits 134: Becton Dickinson and Co. - Segment focus
Exhibits 135: Eli Lilly and Co. - Overview
Exhibits 136: Eli Lilly and Co. - Product / Service
Exhibits 137: Eli Lilly and Co. - Key news
Exhibits 138: Eli Lilly and Co. - Key offerings
Exhibits 139: F. Hoffmann La Roche Ltd. - Overview
Exhibits 140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 141: F. Hoffmann La Roche Ltd. - Key news
Exhibits 142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 144: GlaxoSmithKline Plc - Overview
Exhibits 145: GlaxoSmithKline Plc - Business segments
Exhibits 146: GlaxoSmithKline Plc - Key news
Exhibits 147: GlaxoSmithKline Plc - Key offerings
Exhibits 148: GlaxoSmithKline Plc - Segment focus
Exhibits 149: Halozyme Therapeutics Inc. - Overview
Exhibits 150: Halozyme Therapeutics Inc. - Product / Service
Exhibits 151: Halozyme Therapeutics Inc. - Key offerings
Exhibits 152: Merck KGaA - Overview
Exhibits 153: Merck KGaA - Business segments
Exhibits 154: Merck KGaA - Key news
Exhibits 155: Merck KGaA - Key offerings
Exhibits 156: Merck KGaA - Segment focus
Exhibits 157: Owen Mumford Ltd. - Overview
Exhibits 158: Owen Mumford Ltd. - Product / Service
Exhibits 159: Owen Mumford Ltd. - Key offerings
Exhibits 160: Pfizer Inc. - Overview
Exhibits 161: Pfizer Inc. - Product / Service
Exhibits 162: Pfizer Inc. - Key news
Exhibits 163: Pfizer Inc. - Key offerings
Exhibits 164: Recipharm AB - Overview
Exhibits 165: Recipharm AB - Business segments
Exhibits 166: Recipharm AB - Key offerings
Exhibits 167: Recipharm AB - Segment focus
Exhibits 168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 173: Viatris Inc. - Overview
Exhibits 174: Viatris Inc. - Business segments
Exhibits 175: Viatris Inc. - Key news
Exhibits 176: Viatris Inc. - Key offerings
Exhibits 177: Viatris Inc. - Segment focus
Exhibits 178: Ypsomed Holding AG - Overview
Exhibits 179: Ypsomed Holding AG - Business segments
Exhibits 180: Ypsomed Holding AG - Key offerings
Exhibits 181: Ypsomed Holding AG - Segment focus
Exhibits 182: Inclusions checklist
Exhibits 183: Exclusions checklist
Exhibits 184: Currency conversion rates for US$
Exhibits 185: Research methodology
Exhibits 186: Information sources
Exhibits 187: Data validation
Exhibits 188: Validation techniques employed for market sizing
Exhibits 189: Data synthesis
Exhibits 190: 360 degree market analysis
Exhibits 191: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global autoinjectors market: AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic alliances between companies."

According to the report, one of the major drivers for this market is the increasing prevalence of allergies and need for immediate care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • Bayer AG
  • Becton Dickinson and Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Halozyme Therapeutics Inc.
  • Johnson and Johnson Services Inc.
  • Johnson Medtech LLC
  • medmix Ltd.
  • Merck KGaA
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • RAVIMED Sp. zoo
  • Recipharm AB
  • SHL Medical AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Ypsomed Holding AG